Investigational New Lupus Drug Shown Safe and Effective in Trial Led by Dr. Daniel Wallace, S.L.E. Lupus Foundation Board Member
by Chris Burton
The new drug in development, epratuzumab, was shown effective and well tolerated in a Phase 2 trial led by world-renowned lupus expert Dr. Daniel Wallace, member of the Board of Directors of our New York organization, the S.L.E. Lupus Foundation.